Skip to main content
. 2022 Apr 23;23(9):4664. doi: 10.3390/ijms23094664

Figure 6.

Figure 6

Illustration of the significant N-glycan signatures of serum IgG1, 2, and 4 associated specifically to IMN or both IMN and pathological controls. Features indicated with a star were more pronounced in high PLA2R Ab titer IMN patients. The stringency (yellow/blue box) refers to the significance considering both matching approaches.